BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 17318220)

  • 1. Protein phosphatase 1 nuclear targeting subunit is a hypoxia inducible gene: its role in post-translational modification of p53 and MDM2.
    Lee SJ; Lim CJ; Min JK; Lee JK; Kim YM; Lee JY; Won MH; Kwon YG
    Cell Death Differ; 2007 Jun; 14(6):1106-16. PubMed ID: 17318220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
    Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
    Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Stabilization and accumulation induced by human vaccinia-related kinase 1.
    Vega FM; Sevilla A; Lazo PA
    Mol Cell Biol; 2004 Dec; 24(23):10366-80. PubMed ID: 15542844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the antagonism of retinoblastoma protein dephosphorylation by PNUTS provides insights into the PP1 regulatory code.
    Choy MS; Hieke M; Kumar GS; Lewis GR; Gonzalez-DeWhitt KR; Kessler RP; Stein BJ; Hessenberger M; Nairn AC; Peti W; Page R
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4097-102. PubMed ID: 24591642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role for Daxx in regulating Mdm2.
    Tang J; Qu LK; Zhang J; Wang W; Michaelson JS; Degenhardt YY; El-Deiry WS; Yang X
    Nat Cell Biol; 2006 Aug; 8(8):855-62. PubMed ID: 16845383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
    Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
    Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
    Kulikov R; Boehme KA; Blattner C
    Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin increases the p53/MDM2 protein ratio and p53-dependent apoptosis by translational inhibition of mdm2 in cancer cells.
    Kao CL; Hsu HS; Chen HW; Cheng TH
    Cancer Lett; 2009 Dec; 286(2):250-9. PubMed ID: 19560264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified.
    Mayo LD; Seo YR; Jackson MW; Smith ML; Rivera Guzman J; Korgaonkar CK; Donner DB
    J Biol Chem; 2005 Jul; 280(28):25953-9. PubMed ID: 15843377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
    Wunderlich M; Berberich SJ
    Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity.
    Phillips A; Teunisse A; Lam S; Lodder K; Darley M; Emaduddin M; Wolf A; Richter J; de Lange J; Verlaan-de Vries M; Lenos K; Böhnke A; Bartel F; Blaydes JP; Jochemsen AG
    J Biol Chem; 2010 Sep; 285(38):29111-27. PubMed ID: 20659896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.
    Pavithra L; Mukherjee S; Sreenath K; Kar S; Sakaguchi K; Roy S; Chattopadhyay S
    J Mol Biol; 2009 May; 388(4):691-702. PubMed ID: 19303885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PKB/Akt activation inhibits p53-mediated HIF1A degradation that is independent of MDM2.
    Choy MK; Movassagh M; Bennett MR; Foo RS
    J Cell Physiol; 2010 Mar; 222(3):635-9. PubMed ID: 19950214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of PNUTS leads to activation of Rb-phosphatase and caspase-mediated apoptosis.
    De Leon G; Sherry TC; Krucher NA
    Cancer Biol Ther; 2008 Jun; 7(6):833-41. PubMed ID: 18360108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel function of orphan nuclear receptor Nur77 in stabilizing hypoxia-inducible factor-1alpha.
    Yoo YG; Yeo MG; Kim DK; Park H; Lee MO
    J Biol Chem; 2004 Dec; 279(51):53365-73. PubMed ID: 15385570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of PLAGL2 in activation of iron deficient- and hypoxia-induced gene expression in mouse cell lines.
    Furukawa T; Adachi Y; Fujisawa J; Kambe T; Yamaguchi-Iwai Y; Sasaki R; Kuwahara J; Ikehara S; Tokunaga R; Taketani S
    Oncogene; 2001 Aug; 20(34):4718-27. PubMed ID: 11498794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
    Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
    FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities.
    Li DW; Liu JP; Schmid PC; Schlosser R; Feng H; Liu WB; Yan Q; Gong L; Sun SM; Deng M; Liu Y
    Oncogene; 2006 May; 25(21):3006-22. PubMed ID: 16501611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of RNA Pol II Speed by PNUTS-PP1 and Spt5 Dephosphorylation Facilitates Termination by a "Sitting Duck Torpedo" Mechanism.
    Cortazar MA; Sheridan RM; Erickson B; Fong N; Glover-Cutter K; Brannan K; Bentley DL
    Mol Cell; 2019 Dec; 76(6):896-908.e4. PubMed ID: 31677974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the regulation of p53 activation by HIF-1 upon hypoxia.
    Wang P; Guan D; Zhang XP; Liu F; Wang W
    FEBS Lett; 2019 Sep; 593(18):2596-2611. PubMed ID: 31282018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.